Communicators

are winners!

More News

23.05.2025
Onco-Innovations Announces Appointment of Professor Steven Jones as Senior Scientific Advisor, Strengthening Technical Acumen in AI-Powered Precision Oncology
17.05.2025
Onco-Innovations Celebrates Listing of Common Shares on Cboe Canada
25.04.2025
Onco-Innovations’ Inka Health Signs New Analytical Work with AstraZeneca Canada to Advance Real-World Evidence in Regulatory Science
23.04.2025
Dr. James Orbinski Joins Onco-Innovations’ Scientific and Clinical Advisory Board to Bolster Company’s Mission
18.04.2025
Onco-Innovations Announces Partnership with Dalton Pharma for Isotope Synthesis of Patented PNKP Technology
11.04.2025
Onco-Innovations’ Inka Health Publishes Roche-Sponsored Study Advancing Real-World Oncology Research
04.04.2025
Onco-Innovations’ Inka Health Completes Analytical Work for AstraZeneca Canada, Advancing Pharmaceutical Analytics and Leading to Key Studies at ISPOR 2025
26.03.2025
Onco-Innovations' PKNP Technology Used with Radiation Therapy Shown in Study to Demonstrate Low Toxicity and High Safety Profile
03.03.2025
Onco-Innovations CEO Thomas O’Shaughnessy Featured on Conversations That Matter to Discuss Breakthroughs in Cancer Treatment, AI Integration, and Potential Global Expansion
28.02.2025
Onco-Innovations’ Inka Health Innovative AI-Driven Oncology Study Paves the Way for New Research